Ramazan Idılman

11.9k total citations
176 papers, 4.0k citations indexed

About

Ramazan Idılman is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ramazan Idılman has authored 176 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Hepatology, 131 papers in Epidemiology and 29 papers in Surgery. Recurrent topics in Ramazan Idılman's work include Liver Disease Diagnosis and Treatment (94 papers), Hepatitis C virus research (89 papers) and Hepatitis B Virus Studies (79 papers). Ramazan Idılman is often cited by papers focused on Liver Disease Diagnosis and Treatment (94 papers), Hepatitis C virus research (89 papers) and Hepatitis B Virus Studies (79 papers). Ramazan Idılman collaborates with scholars based in Türkiye, United States and Germany. Ramazan Idılman's co-authors include Cihan Yurdaydın, David H. Van Thiel, Alessandra Colantoni, Mithat Bozdayı, Berna Savaş, Nicola De Maria, Atilla Halil Elhan, Onur Keskın, Muşturay Karçaaltıncaba and Ilkay S. Idılman and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Ramazan Idılman

168 papers receiving 3.9k citations

Peers

Ramazan Idılman

EPIDE

HEPAT

SURGE

EDM

Zu‐Yau Lin Taiwan

Dominique Roulot France

John Koskinas Greece

Hiroshi Yatsuhashi Japan

Kojiro Michitaka Japan

Chien‐Hung Chen Taiwan

Donald M. Jensen United States

Jean‐Pierre Zarski France

Takeji Umemura Japan

Hyung Joon Yim South Korea

Zu‐Yau Lin Taiwan

Ramazan Idılman

2.8k ×0.9

EPIDE

3.0k ×1.1

HEPAT

351 ×0.7

SURGE

538 ×1.7

231 ×0.9

EDM

Citations per year, relative to Ramazan Idılman Ramazan Idılman (= 1×) peers Zu‐Yau Lin

Countries citing papers authored by Ramazan Idılman

Since Specialization

Citations

This map shows the geographic impact of Ramazan Idılman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramazan Idılman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramazan Idılman more than expected).

Fields of papers citing papers by Ramazan Idılman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramazan Idılman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramazan Idılman. The network helps show where Ramazan Idılman may publish in the future.

Co-authorship network of co-authors of Ramazan Idılman

This figure shows the co-authorship network connecting the top 25 collaborators of Ramazan Idılman. A scholar is included among the top collaborators of Ramazan Idılman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramazan Idılman. Ramazan Idılman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gürakar, Merve, et al.. (2025). Updates on Recent Advancements in Hepatitis D Virus Treatment. Viruses. 17(8). 1100–1100. 1 indexed citations

Öz, Diğdem Kuru, Mesut Gümüşsoy, Saba Kiremitçi, et al.. (2024). Assessing hepatic steatosis by magnetic resonance in potential living liver donors. Diagnostic and Interventional Radiology. 0(0). 0–0. 2 indexed citations

Kalkan, Çağdaş, Beyza Doğanay Erdoğan, Berna Savaş, et al.. (2023). Non‐invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta. Journal of Viral Hepatitis. 30(5). 406–416. 8 indexed citations

Gümüşsoy, Mesut, Beyza Doğanay Erdoğan, Meltem Bingöl‐Koloğlu, et al.. (2023). Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience. The Turkish Journal of Gastroenterology. 34(2). 177–181. 2 indexed citations

Özaslan, Ersan, Fulya Günşar, İbrahim Hatemı, et al.. (2023). Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver. The Turkish Journal of Gastroenterology. 34(3). S1–S33. 3 indexed citations

Akarca, Ulus Salih, Nurcan Baykam, Rahmet Güner, et al.. (2022). Eliminating Viral Hepatitis in Turkey: Achievements and Challenges. Viral Hepatitis Journal. 28(2). 47–54. 4 indexed citations

Kaya, Cansın Tulunay, Çağlar Uzun, Elif Peker, et al.. (2022). Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease. The Turkish Journal of Gastroenterology. 34(3). 242–253.

Akarca, Ulus Salih, Belkıs Ünsal, Orhan Sezgın, et al.. (2021). Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. The Turkish Journal of Gastroenterology. 32(12). 1019–1028. 2 indexed citations

Akarsu, Mesut, İlker Turan, Gupse Adalı, et al.. (2021). Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. The Turkish Journal of Gastroenterology. 32(9). 712–719. 6 indexed citations

10.

Idılman, Ramazan, Fatih Karakaya, Çağdaş Kalkan, et al.. (2019). Etiology of cirrhosis changing trends over the years: A single-center turkish experience. The Turkish Journal of Gastroenterology. 30(Supp1). 66–66. 1 indexed citations

11.

Campenhout, Margo J. H. van, Willem Pieter Brouwer, Qing Xie, et al.. (2018). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis. 26(1). 109–117. 14 indexed citations

12.

Yurdaydın, Cihan, Onur Keskın, Çağdaş Kalkan, et al.. (2017). Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 study. Hepatology. 67(4). 1224–1236. 103 indexed citations

13.

Idılman, Ramazan. (2017). The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. The Turkish Journal of Gastroenterology. 28(5). 412–416. 20 indexed citations

14.

Tözün, Nurdan, Osman Özdoğan, Yılmaz Çakaloğlu, et al.. (2015). Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection. 21(11). 1020–1026. 173 indexed citations

15.

Gürakar, Merve, et al.. (2014). Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy. The Turkish Journal of Gastroenterology. 25(3). 304–308. 9 indexed citations

16.

Karataylı, Senem Ceren, Ersin Karataylı, Onur Keskın, et al.. (2014). Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency. The Turkish Journal of Gastroenterology. 25(4). 405–410. 15 indexed citations

17.

Bakanay, Şule Mine, Mehmet Bektaş, Ramazan Idılman, et al.. (2013). Vanishing bile duct syndrome after allogeneic bone marrow transplantation: Is it the end of the road?. The Turkish Journal of Gastroenterology. 24(4). 359–362. 1 indexed citations

18.

Engin, Ayşe Başak, Fatih Oğuz Önder, Mehmet Bektaş, et al.. (2009). Aflatoxin exposure in viral hepatitis patients in Turkey. The Turkish Journal of Gastroenterology. 20(3). 192–197. 11 indexed citations

19.

Yurdaydın, Cihan, et al.. (2008). 685 ADEFOVIR TREATMENT OF ENTECAVIR RESISTANCE IN PATIENTS WITH LAMIVUDINE-REFRACTORY CHRONIC HEPATITIS B. Journal of Hepatology. 48. S255–S255. 1 indexed citations

20.

Ertek, Sibel, Mutlu Arat, İrfan Soykan, et al.. (2005). Fatal fulminant hepatic failure during treatment of multiple myeloma. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 58(3). 146–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact